0.4194
price up icon0.33%   0.0014
after-market Dopo l'orario di chiusura: .42 0.0006 +0.14%
loading

Jaguar Health Inc Borsa (JAGX) Ultime notizie

pulisher
Mar 21, 2026

Will Jaguar Health Inc outperform the market in YEAR2026 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

Should value investors consider Jaguar Health Inc2026 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 19, 2026

JAGX Forecast, Price Target & Analyst Ratings | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill

Mar 19, 2026
pulisher
Mar 18, 2026

Jaguar Health (JAGX) Advances Pediatric Crofelemer Study - GuruFocus

Mar 18, 2026
pulisher
Mar 18, 2026

FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Yahoo! Finance Canada

Mar 18, 2026
pulisher
Mar 18, 2026

Published on: 2026-03-19 06:11:46 - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Earnings Recap: Is Jaguar Health Inc stock a top performer YTDDay Trade & Real-Time Market Sentiment Alerts - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Seacoastonline.com

Mar 17, 2026
pulisher
Mar 17, 2026

Jaguar Health unit begins coca extract study for weight management By Investing.com - Investing.com South Africa

Mar 17, 2026
pulisher
Mar 16, 2026

Jaguar Health (JAGX) Launches Preclinical Study on Coca Leaf Ext - GuruFocus

Mar 16, 2026
pulisher
Mar 16, 2026

Jaguar Health unit begins coca extract study for weight management - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - ACCESS Newswire

Mar 16, 2026
pulisher
Mar 16, 2026

Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - FinanzNachrichten.de

Mar 16, 2026
pulisher
Mar 16, 2026

Can coca leaves help keep weight off after GLP-1 drugs end? - Stock Titan

Mar 16, 2026
pulisher
Mar 15, 2026

Jaguar Health, Inc. Trade Ideas — GETTEX:1JA0 - TradingView

Mar 15, 2026
pulisher
Mar 14, 2026

Performance Recap: Will Jaguar Health Inc benefit from AI trends2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn

Mar 14, 2026
pulisher
Mar 13, 2026

Jaguar Health (NASDAQ: JAGX) asks shareholders to OK reverse splits, large potential dilution - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

JAGX Stock Price, Quote & Chart | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill

Mar 13, 2026
pulisher
Mar 12, 2026

Jaguar Health at Life Sciences Forum: Strategic Shift to Rare Diseases - Investing.com

Mar 12, 2026
pulisher
Mar 12, 2026

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Sheboygan Press

Mar 12, 2026
pulisher
Mar 12, 2026

Director John Micek granted stock options and RSUs at Jaguar Health (JAGX) - Stock Titan

Mar 12, 2026
pulisher
Mar 11, 2026

Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts - Bradenton Herald

Mar 11, 2026
pulisher
Mar 11, 2026

User - The Chronicle-Journal

Mar 11, 2026
pulisher
Mar 11, 2026

Published on: 2026-03-11 18:03:23 - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 09, 2026

Jaguar Health (JAGX) Restructures Debt and Reduces Royalties - GuruFocus

Mar 09, 2026
pulisher
Mar 09, 2026

Jaguar Health, Inc. Enters Global Amendment Agreements and Security Agreement – March 2026 8-K Filing Details - Minichart

Mar 09, 2026
pulisher
Mar 09, 2026

According to the latest SEC filing, Jaguar Health Inc (NASDAQ: JAGX) has completed the amendment to the Uptown 2020 royalty interest agreement. - Bitget

Mar 09, 2026
pulisher
Mar 09, 2026

Jaguar Animal Health Restructures Debt and Royalty Agreements - TipRanks

Mar 09, 2026
pulisher
Mar 09, 2026

Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants - ACCESS Newswire

Mar 09, 2026
pulisher
Mar 09, 2026

Jaguar Health Extends Debt, Defers Royalty Payments; Terminates 48,211-Share Warrants - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

Debt extensions and warrant termination reshape Jaguar Health (NASDAQ: JAGX) - Stock Titan

Mar 09, 2026
pulisher
Mar 09, 2026

Jaguar Health trims $3M in debt and royalties, extends loans to July 2026 - Stock Titan

Mar 09, 2026
pulisher
Mar 08, 2026

Jaguar Health executes strategic stock exchange agreements - MSN

Mar 08, 2026
pulisher
Mar 07, 2026

Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1 - ACCESS Newswire

Mar 07, 2026
pulisher
Mar 07, 2026

JAGXJaguar Health Announces a Special One-time Stock Dividend - mx.advfn.com

Mar 07, 2026
pulisher
Mar 06, 2026

Jaguar Health receives Nasdaq delisting notice after share price falls below $1 - Investing.com

Mar 06, 2026
pulisher
Mar 06, 2026

Revenue Check: Is Jaguar Health Inc gaining market shareJuly 2025 Weekly Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Jaguar Health Faces Nasdaq Delisting, Plans to Appeal - TipRanks

Mar 06, 2026
pulisher
Mar 06, 2026

Jaguar Health Received Notice of Delisting - TradingView

Mar 06, 2026
pulisher
Mar 06, 2026

Jaguar Health (NASDAQ: JAGX) confronts Nasdaq delisting risk after bid-price breach - Stock Titan

Mar 06, 2026
pulisher
Mar 04, 2026

Jaguar Animal Health Declares Special Series O Dividend - The Globe and Mail

Mar 04, 2026
pulisher
Mar 03, 2026

Jaguar Health receives $3M from Future Pak licensing deal By Investing.com - Investing.com India

Mar 03, 2026
pulisher
Mar 03, 2026

Jaguar Health receives $3M from Future Pak licensing deal - Investing.com South Africa

Mar 03, 2026
pulisher
Mar 03, 2026

Jaguar Animal Health Issues Racing Data Summary for Horses Participating in the Company’s Recently Completed Dose Determina... - mx.advfn.com

Mar 03, 2026
pulisher
Mar 03, 2026

Jaguar Animal Health and Henry Schein, Inc. Sign Exclusive Distribution Agreement for Neonorm Foal - Revista ADVFN

Mar 03, 2026
pulisher
Mar 03, 2026

Jaguar Health announces Series O preferred stock dividend and new certificate of designation - Investing.com Nigeria

Mar 03, 2026
pulisher
Mar 03, 2026

Jaguar Health (JAGX) Secures $3M Payment From Future Pak - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

[8-K] Jaguar Health, Inc. Reports Material Event | JAGX SEC FilingForm 8-K - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Jaguar Health adds $3M as it targets crofelemer for rare intestinal failure - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jaguar Health, Inc.Common Stock (NQ: JAGX - The Chronicle-Journal

Mar 02, 2026
$45.36
price down icon 0.37%
$27.70
price down icon 0.36%
$51.38
price down icon 1.89%
$89.27
price down icon 0.04%
$136.00
price down icon 5.56%
ONC ONC
$275.28
price down icon 2.63%
Capitalizzazione:     |  Volume (24 ore):